Indian pharma juggernaut Lupin—best known in the U.S. for its portfolio of generic drugs—is laying down new manufacturing roots in Florida. Lupin expects to invest a combined $250 million—covering R&D ...

A closer look at how robotics is reshaping pharmaceutical manufacturing, from improving quality and compliance to enabling more scalable production, and where the technology is headed next.

QUEBEC CITY, March 17, 2026 /CNW/ - OPTEL, a global leader in traceability and compliance solutions, and Kaster Technologies, a specialist in AI-powered production planning intelligence software, have ...

In a bid to deepen its manufacturing foothold in the U.S., Regeneron Pharmaceuticals in April pledged production and infrastructure investments surpassing $7 billion across North Carolina and its ...

WASHINGTON—President Trump announced many new tariffs Thursday, including a large one on drugs from pharmaceutical companies that aren’t building plants in the U.S. “Starting October 1st, 2025, we ...

The two new facilities will create 300 jobs and are part of the drugmaker’s broader plan to invest $100 billion in the U.S. over the next decade.

President Donald Trump announced a new set of tariffs on Thursday evening, including a 100% levy on patented drugs unless a company is building a plant to manufacture in the U.S., triggering a steep ...

Minister of Health and Media, Dr. Nalinda Jayatissa, conducted an inspection tour of two large-scale pharmaceutical manufacturing companies in Sri Lanka, Kelun LifeScience (Pvt.) Ltd., and Celogen ...